These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18662290)

  • 1. Does the European clinical trials directive really improve clinical trial approval time?
    Lambers Heerspink HJ; Dobre D; Hillege HL; Grobbee DE; de Zeeuw D
    Br J Clin Pharmacol; 2008 Oct; 66(4):546-50. PubMed ID: 18662290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union.
    Ramirez I
    Ger Med Sci; 2015; 13():Doc21. PubMed ID: 26633964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-marketing authorisation submission assessments in Europe.
    Morgan L
    Therapie; 2005; 60(3):205-8. PubMed ID: 16128260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. '(More) trials and tribulations': the effect of the EU directive on clinical trials in intensive care and emergency medicine, five years after its implementation.
    Robinson K; Andrews PJ
    J Med Ethics; 2010 Jun; 36(6):322-5. PubMed ID: 20530086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries.
    Hartmann M
    Trials; 2012 Apr; 13():53. PubMed ID: 22540886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 8. How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI study.
    Timmers M; van Dijck JTJM; van Wijk RPJ; Legrand V; van Veen E; Maas AIR; Menon DK; Citerio G; Stocchetti N; Kompanje EJO;
    BMC Med Ethics; 2020 May; 21(1):36. PubMed ID: 32398066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
    Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
    Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK.
    Hearn J; Sullivan R
    Eur J Cancer; 2007 Jan; 43(1):8-13. PubMed ID: 17118647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The regulatory framework for complementary and alternative medicines in Europe].
    Knöss W; Stolte F; Reh K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):771-8. PubMed ID: 18584103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research ethics committees and post-approval activities: a qualitative study on the perspectives of European research ethics committee representatives.
    Cox S; Solbakk JH; Bernabe RDLC
    Curr Med Res Opin; 2022 Nov; 38(11):1897-1907. PubMed ID: 35993742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new approval procedure for clinical trials of medicinal products in the European Union-challenges for the pharmaceutical industry in Germany].
    Henn DK; Ruppert T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jan; 66(1):28-37. PubMed ID: 36449064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Trial Application in Europe: What Will Change with the New Regulation?
    Giannuzzi V; Altavilla A; Ruggieri L; Ceci A
    Sci Eng Ethics; 2016 Apr; 22(2):451-66. PubMed ID: 26037896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis.
    Murray E; McAdam R; Burke MT
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 2004; 17(7):389-93. PubMed ID: 15552394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A future for regulatory science in the European Union: the European Medicines Agency's strategy.
    Hines PA; Janssens R; Gonzalez-Quevedo R; Lambert AIOM; Humphreys AJ
    Nat Rev Drug Discov; 2020 May; 19(5):293-294. PubMed ID: 32235873
    [No Abstract]   [Full Text] [Related]  

  • 18. Researchers see a need for speed in EU trial approvals.
    Cressey D
    Nat Med; 2008 Aug; 14(8):794. PubMed ID: 18685580
    [No Abstract]   [Full Text] [Related]  

  • 19. India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs.
    Sharma DC
    Lancet; 2004 May; 363(9420):1528-9. PubMed ID: 15139330
    [No Abstract]   [Full Text] [Related]  

  • 20. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.